Sam Brusco, Associate Editor04.15.24
Exact Sciences has appointed Aaron Bloomer as its new chief financial officer. Bloomer will take office on May 15, 2024.
Bloomer has over 15 years of finance and accounting experience. He had prior leadership positions at Baxter International and 3M—at Baxter, he led corporate financial planning, reporting and analytics (FP&A) as vice president.
Before that, he spent over a decade at 3M, where he served as senior vice president of FP&A, as well as CFO for 3M China and one of the firm’s divisions in Tokyo, Japan.
“Aaron comes to us with significant global experience setting corporate strategy and driving growth and operational discipline from his leadership roles at incredible companies,” Exact Sciences CEO Kevin Conroy told the press. “We are excited to welcome a leader of Aaron’s caliber to our executive team. As we look to bring our portfolio of tests to more patients around the world, Aaron’s oversight will help us further our mission of helping to eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment.”
Bloomer will join the cancer screening and diagnostics company as executive VP of finance immediately to help facilitate a smooth transition. He will then succeed current CFO Jeff Elliott after a 30-day transition period. Elliott is slated to become special advisor to the CEO.
“I am energized by the opportunity to join a company with such an important mission and to play a meaningful role in Exact Sciences’ growth trajectory,” said Bloomer. “Throughout my career, I have applied a relentlessly competitive and innovative mindset to drive growth and success. I plan to do the same as CFO, with a focus on superior financial and operational execution.”
Bloomer has over 15 years of finance and accounting experience. He had prior leadership positions at Baxter International and 3M—at Baxter, he led corporate financial planning, reporting and analytics (FP&A) as vice president.
Before that, he spent over a decade at 3M, where he served as senior vice president of FP&A, as well as CFO for 3M China and one of the firm’s divisions in Tokyo, Japan.
“Aaron comes to us with significant global experience setting corporate strategy and driving growth and operational discipline from his leadership roles at incredible companies,” Exact Sciences CEO Kevin Conroy told the press. “We are excited to welcome a leader of Aaron’s caliber to our executive team. As we look to bring our portfolio of tests to more patients around the world, Aaron’s oversight will help us further our mission of helping to eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment.”
Bloomer will join the cancer screening and diagnostics company as executive VP of finance immediately to help facilitate a smooth transition. He will then succeed current CFO Jeff Elliott after a 30-day transition period. Elliott is slated to become special advisor to the CEO.
“I am energized by the opportunity to join a company with such an important mission and to play a meaningful role in Exact Sciences’ growth trajectory,” said Bloomer. “Throughout my career, I have applied a relentlessly competitive and innovative mindset to drive growth and success. I plan to do the same as CFO, with a focus on superior financial and operational execution.”